Skip to main content
. 2023 Jun 13;9(2):108–125. doi: 10.1136/svn-2022-002246

Figure 9.

Figure 9

Different poly(A) binding protein cytoplasmic 1 (PABPC1) expression levels affected the survival of patients with pan-cancer. (A) Overall survival (OS), disease-specific survival (DSS) and progression-free interval (PFI) in patients with PABPC1 had different manifestations in pan-cancer. (B) Patients with high or low expression of PABPC1 had different overall survival curves in different type of tumors.